Biotech Vividion lands $135M in crossover cash, paving a path to the public markets

money, dollar

  Vividion Therapeutics has technology that finds ways to hit promising disease targets that were previously deemed “undruggable.” Now it has $135 million that might allow it to find something else: a public stock listing. The Series C round of

Read More Biotech Vividion lands $135M in crossover cash, paving a path to the public markets

FDA lays out shortened path for testing vaccines against new coronavirus variants

Visby gets FDA nod for single-use, rapid point-of-care COVID-19 PCR test

Dive Brief: Coronavirus vaccine developers can rely on smaller clinical trials involving just a few hundred volunteers to test whether updated versions of authorized shots protect against emerging viral strains, the Food and Drug Administration said Monday. Such studies would

Read More FDA lays out shortened path for testing vaccines against new coronavirus variants

Amicus’s path to unseat Sanofi in rare disease gets steeper after Phase 3 miss

Amicus’s path to unseat Sanofi in rare disease gets steeper after Phase 3 miss

  Amicus Therapeutics aims to position its experimental Pompe disease treatment as the new standard of care, supplanting a therapy from Sanofi. But securing approval will require explaining to regulators why they should look past the treatment’s failure to achieve

Read More Amicus’s path to unseat Sanofi in rare disease gets steeper after Phase 3 miss

CMS rejects 1st colorectal cancer blood test, tweaks path for Exact, Guardant and others

CMS rejects 1st colorectal cancer blood test, tweaks path for Exact, Guardant and others

Dive Brief: CMS has finalized its rejection of Epigenomics’ blood-based colorectal cancer screening test, depriving the company of the chance to sell the liquid biopsy for Medicare beneficiaries. Epigenomics is considering an appeal or litigation after CMS published a final decision

Read More CMS rejects 1st colorectal cancer blood test, tweaks path for Exact, Guardant and others

By protecting the healthcare safety net, Biden can put us on the path to a stronger country

By protecting the healthcare safety net, Biden can put us on the path to a stronger country

When President-elect Joe Biden received his second dose of COVID-19 vaccine last week, it came at a Newark, Del., essential hospital, one of hundreds nationwide that make it their mission to care for everyone—from dignitaries to our most underrepresented people.

Read More By protecting the healthcare safety net, Biden can put us on the path to a stronger country

Current Status of the Title X Network and the Path Forward

Current Status of the Title X Network and the Path Forward

President-elect Joe Biden campaigned on restoring the Title X family planning program that has been diminished under the Trump Administration. The Biden Administration will likely take executive action to reverse the Trump Administration regulations and restore access to Title X

Read More Current Status of the Title X Network and the Path Forward

It’s time for a conversation on transformation; but know the pitfalls along the path to change

It's time for a conversation on transformation; but know the pitfalls along the path to change

The words coronavirus and healthcare are inextricably intertwined. However, one needs to only listen for a moment, and invariably, a third word emerges: change. 
It is time for the healthcare industry to begin a crucial conversation about change. As a

Read More It’s time for a conversation on transformation; but know the pitfalls along the path to change

Kristen Bell: Advocate for the Homeless

Which HCPs Are Most Likely to Get COVID Vaccine?

Last March, when the extent of the coronavirus pandemic was just beginning to sink in as schools and businesses across the nation started to close, actor Kristen Bell learned that the government in Italy — already devastated by the

Read More Kristen Bell: Advocate for the Homeless

3 key technology elements needed to accelerate a path to drug discovery

3 key technology elements needed to accelerate a path to drug discovery

The Covid-19 pandemic has impacted every facet of our society — how we work, live, learn, and play — and normalcy will not return until we find a proven vaccine. While multiple pharmaceutical and biotech companies have raced to develop

Read More 3 key technology elements needed to accelerate a path to drug discovery